Mycobacterium tuberculosis infection in transplant recipients: Early diagnosis and treatment of resistant tuberculosis

Current Opinion in Organ Transplantation

Volumn 14, Issue 6, 2009, Pages 613-618

  Holty, Jon Erik C ^a,b   Sista, Ramachandra R ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY   (United States)

Author keywords

Extensively drug resistant tuberculosis; Mycobacterium tuberculosis; Solid organ transplant

Indexed keywords

ALEMTUZUMAB; AMIKACIN; AMINOSALICYLIC ACID; BCG VACCINE; CAPREOMYCIN; CORTICOSTEROID; CYCLOSERINE; CYCLOSPORIN A; ETHAMBUTOL; ETHIONAMIDE; EVEROLIMUS; IMMUNOSUPPRESSIVE AGENT; ISONIAZID; KANAMYCIN; LINEZOLID; PYRAZINAMIDE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RAPAMYCIN; RIFABUTIN; RIFAMPICIN; RIFAMYCIN; STREPTOMYCIN; TACROLIMUS; TUBERCULOSTATIC AGENT;

ARTHROPATHY; BCG VACCINATION; BEHAVIOR DISORDER; CLINICAL FEATURE; DRUG ELIMINATION; DRUG ERUPTION; DRUG FATALITY; DRUG HYPERSENSITIVITY; DRUG RESISTANT TUBERCULOSIS; EARLY DIAGNOSIS; GASTROINTESTINAL SYMPTOM; GRAFT RECIPIENT; GRAFT REJECTION; HEPATITIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HYPERURICEMIA; IMMUNOSUPPRESSIVE TREATMENT; INFECTION PREVENTION; KIDNEY GRAFT REJECTION; LACTIC ACIDOSIS; LEUKOPENIA; LIVER TOXICITY; LUNG TRANSPLANTATION; LUNG TUBERCULOSIS; NEPHROTOXICITY; ORGAN TRANSPLANTATION; OTOTOXICITY; PANCYTOPENIA; PATHOGENESIS; PERIPHERAL NEUROPATHY; PHOTODERMATOSIS; POLYNEUROPATHY; PREVALENCE; RETROBULBAR OPTIC NEUROPATHY; REVIEW; SEIZURE; THROMBOCYTOPENIA; TUBERCULIN TEST; TUBERCULOSIS;

ANTITUBERCULAR AGENTS; EARLY DIAGNOSIS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LATENT TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; ORGAN TRANSPLANTATION; PREVALENCE; TREATMENT OUTCOME; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 74349091157     PISSN: 10872418     EISSN: 15317013     Source Type: Journal    
DOI: 10.1097/MOT.0b013e3283324dfc     Document Type: Review

References (59)

1. Organ Procurement and Transplantation Network (OPTN). Transplant data [Database]. Richmond, Virginia: U.S. Department of Health & Human Services. http://optn.transplant.hrsa.gov. [Accessed 1 July 2009].
2. Fishman JA, Fishman JA. Infection in solid-organ transplant recipients. N Engl J Med 2007; 357:2601-2614.
3. Global tuberculosis control: surveillance, planning, financing. WHO Report 2007. Geneva:World Health Organization; 2007 (WHO/HTM/TB/2007.376).
4. Hauck FR, Neese BH, Panchal AS, et al. Identification and management of latent tuberculosis infection. Am Fam Physician 2009; 79:879-886.
5. Maartens G, Wilkinson RJ. Tuberculosis. Lancet 2007; 370:2030-2043.
6. Aguado JM, Torre-Cisneros J, Fortun J, et al. Tuberculosis in solid-organ transplant recipients: consensus statement of the group for the study of infection in transplant recipients (GESITRA) of the Spanish Society of Infectious Diseases and Clinical Microbiology. Clin Infect Dis 2009; 48: 1276-1284.
7. Torre-Cisneros J, Doblas A, Aguado JM, et al. Tuberculosis after solid-organ transplant: incidence, risk factors, and clinical characteristics in the RESITRA (Spanish Network of Infection in Transplantation) cohort. Clin Infect Dis 2009; 48:1657-1665.
8. Kliiman K, Altraja A. Predictors of extensively drug-resistant pulmonary tuberculosis. Ann Intern Med 2009; 150:766-775.
9. Centers for Disease Control and Prevention (CDC). Transplantation- transmitted tuberculosis-Oklahoma and Texas, 2007. MMWR Morb Mortal Wkly Rep 2008; 57:333-336.
10. Holty JEC, Gould MK, Meinke L, et al. Tuberculosis in liver transplant recipients: a systematic review and meta-analysis of individual patient data. Liver Transpl 2009; 15:894-906.
11. Wong CF, Fung SL, Yan SW, et al. Lung transplantation in Hong Kong: 12 years of experience. Respirology 2008; 13:903-907.
12. Munoz P, Rodriguez C, Bouza E. Mycobacterium tuberculosis infection in recipients of solid organ transplants. Clin Infect Dis 2005; 40:581-587. (Pubitemid 40270229)
13. Walsh R, Ortiz J, Foster P, et al. Fungal and mycobacterial infections after Campath (alemtuzumab) induction for renal transplantation. Transpl Infect Dis 2008; 10:236-239.
14. Singh N, Paterson DL. Mycobacterium tuberculosis infection in solid-organ transplant recipients: impact and implications for management. Clin Infect Dis 1998; 27:1266-1277.
15. Clemente WT, Faria LC, Lima SS, et al. Tuberculosis in liver transplant recipients: a single Brazilian center experience. Transplantation 2009; 87:397-401.
16. Zhang XF, Lv Y, Xue WJ, et al. Mycobacterium tuberculosis infection in solid organ transplant recipients: experience from a single center in China. Transplant Proc 2008; 40:1382-1385.
17. Chen SY, Wang CX, Chen LZ, et al. Tuberculosis in southern Chinese renaltransplant recipients. Clin Transplant 2008; 22:780-784.
18. Chou NK, Wang JL, Chi NH, et al. Tuberculosis after heart transplantation: twenty years of experience in a single center in Taiwan. Transplant Proc 2008; 40:2631-2633.
19. Ruangkanchanasetr P, Natejumnong C, Kitpanich S, et al. Prevalence and manifestations of tuberculosis in renal transplant recipients: a single-center experience in Thailand. Transplant Proc 2008; 40:2380-2381.
20. Rungruanghiranya S, Ekpanyaskul C, Jirasiritum S, et al. Tuberculosis in Thai renal transplant recipients: a 15-year experience. Transplant Proc 2008; 40:2376-2379.
21. Torres J, Aguado JM, San Juan R, et al. Hepatitis C virus, an important risk factor for tuberculosis in immunocompromised: experience with kidney transplantation. Transpl Int 2008; 21:873-878.
22. Chan AC, Lo CM, Ng KK, et al. Implications for management of Mycobacterium tuberculosis infection in adult-to-adult live donor liver transplantation. Liver Int 2007; 27:81-85.
23. Hsu MS, Wang JL, Ko WJ, et al. Clinical features and outcome of tuberculosis in solid organ transplant recipients. Am J Med Sci 2007; 334:106-110.
24. Kaaroud H, Beji S, Boubaker K, et al. Tuberculosis after renal transplantation. Transplant Proc 2007; 39:1012-1013.
25. Wang B, Lu Y, Yu L, et al. Diagnosis and treatment for tuberculosis infection in liver transplant recipients: case reports. Transplant Proc 2007; 39:3509-3511. (Pubitemid 350251433)
26. Bossert T, Bittner HB, Richter M, et al. Successful management of two heart transplant recipients with mycobacterial pulmonary infections. Ann Thorac Surg 2005; 80:719-721.
27. Bravo C, Roldan J, Roman A, et al. Tuberculosis in lung transplant recipients. Transplantation 2005; 79:59-64.
28. Hsu RB, Fang CT, Chang SC, et al. Infectious complications after heart transplantation in Chinese recipients. Am J Transplant 2005; 5:2011-2016.
29. Morales P, Briones A, Torres JJ, et al. Pulmonary tuberculosis in lung and heart-lung transplantation: fifteen years of experience in a single center in Spain. Transplant Proc 2005; 37:4050-4055.
30. American Thoracic Society; Centers for Disease Control and Prevention; Infectious Diseases Society of America. American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: controlling tuberculosis in the United States. Am J Respir Crit Care Med 2005; 172:1169-1227.
31. Vikrant S, Agarwal SK, Gupta S, et al. Prospective randomized control trial of isoniazid chemoprophylaxis during renal replacement therapy. Transpl Infect Dis 2005; 7:99-108.
32. Agarwal SK, Gupta S, Dash SC, et al. Prospective randomised trial of isoniazid prophylaxis in renal transplant recipient. Int Urol Nephrol 2004; 36:425-431.
33. Naqvi R, Akhtar S, Noor H, et al. Efficacy of isoniazid prophylaxis in renal allograft recipients. Transplant Proc 2006; 38:2057-2058. (Pubitemid 46068459)
34. Nagai S, Fujimoto Y, Taira K, et al. Liver transplantation without isoniazid prophylaxis for recipients with a history of tuberculosis. Clin Transplant 2007; 21:229-234.
35. Jahng AW, Tran T, Bui L, Joyner JL. Safety of treatment of latent tuberculosis infection in compensated cirrhotic patients during transplant candidacy period. Transplantation 2007; 83:1557-1562.
36. American Society of Transplantation. Mycobacterium tuberculosis. Am J Transplant 2004; 4 (Suppl 10):37-41.
37. Menzies D, Pai M, Comstock G. Meta-analysis: new tests for the diagnosis of latent tuberculosis infection-areas of uncertainty and recommendations for research. Ann Intern Med 2007; 146:340-354.
38. Lindemann M, Dioury Y, Beckebaum S, et al. Diagnosis of tuberculosis infection in patients awaiting liver transplantation. Hum Immunol 2009; 70:24-28.
39. Manuel O, Humar A, Preiksaitis J, et al. Comparison of Quantiferon-TB Gold with tuberculin skin test for detecting latent tuberculosis infection prior to liver transplantation. Am J Transplant 2007; 7:2797-2801.
40. Codeluppi M, Cocchi S, Guaraldi G, et al. Posttransplant Mycobacterium tuberculosis disease following liver transplantation and the need for cautious evaluation of Quantiferon TB GOLD results in the transplant setting: a case report. Transplant Proc 2006; 38:1083-1085.
41. Basiri A, Hosseini-Moghaddam SM, Simforoosh N, et al. The risk factors and laboratory diagnostics for post renal transplant tuberculosis: a case-control, country-wide study on definitive cases. Transpl Infect Dis 2008; 10:231-235.
42. Boedefeld RL, Eby J, Boedefeld WM 2nd, et al. Fatal Mycobacterium tuberculosis infection in a lung transplant recipient. J Heart Lung Transplant 2008; 27:1176-1178.
43. Ozbulbul NI, Ozdemir M, Turhan N. CT findings in fatal primary intestinal tuberculosis in a liver transplant recipient. Diagn Intervent Radiol 2008; 14:221-224.
44. Ak O, Dabak G, Ozer S, et al. The evaluation of the Quantiferon-TB Gold test in pulmonary and extrapulmonary tuberculosis. Jpn J Infect Dis 2009; 62: 149-151.
45. Ling DI, Flores LL, Riley LW, Pai M. Commercial nucleic-acid amplification tests for diagnosis of pulmonary tuberculosis in respiratory specimens: metaanalysis and meta-regression. PLoS ONE [Electronic Resource] 2008; 3:e1536.
46. Taylor Z, Nolan CM, Blumberg HM, et al. Controlling tuberculosis in the United States. Recommendations from the American Thoracic Society, CDC, and the Infectious Diseases Society of America. Morbid Mortal Wkly Rep Recomm Rep 2005; 54:1-81.
47. Place S, Knoop C, Remmelink M, et al. Paradoxical worsening of tuberculosis in a heart-lung transplant recipient. Transpl Infect Dis 2007; 9:219-224.
48. Saukkonen JJ, Cohn DL, Jasmer RM, et al. An official ATS statement: hepatotoxicity of antituberculosis therapy.AmJRespir Crit CareMed 2006; 174:935-952.
49. Ho CC, Chen YC, Hu FC, et al. Safety of fluoroquinolone use in patients with hepatotoxicity induced by antituberculosis regimens. Clin Infect Dis 2009; 48:1526-1533.
50. Chen CH, Lian JD, Cheng CH, et al. Mycobacterium tuberculosis infection following renal transplantation in Taiwan. Transpl Infect Dis 2006; 8:148-156.
51. Chan ED, Laurel V, Strand MJ, et al. Treatment and outcome analysis of 205 patients with multidrug-resistant tuberculosis. Am J Respir Crit Care Med 2004; 169:1103-1109.
52. Lee J, Yew WW, Wong CF, et al. Multidrug-resistant tuberculosis in a lung transplant recipient. J Heart Lung Transplant 2003; 22:1168-1173.
53. Di Perri G, Luzzati R, Forni A, et al. Fatal primary multidrug-resistant tuberculosis in a heart transplant recipient. Transpl Int 1998; 11:305-307.
54. Banerjee R, Allen J, Westenhouse J, et al. Extensively drug-resistant tuberculosis in California. Clin Infect Dis 2008; 47:450-457.
55. Centers for Disease Control and Prevention. Emergence of Mycobacterium tuberculosis with extensive resistance to second-line drugs worldwide, 2000-2004. Morbid Mortal Wkly Rep 2006; 55:301-305.
56. Gandhi NR,Moll A, Sturm AW, et al. Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa. Lancet 2006; 368:1575-1580.
57. Centers for Disease Control and Prevention. Extensively drug-resistant tuberculosis-United States, 1993-2006. Morbid Mortal Wkly Rep 2007; 56:250-253.
58. Mohsen T, Zeid AA, Haj-Yahia S. Lobectomy or pneumonectomy for multidrug- resistant pulmonary tuberculosis can be performed with acceptable morbidity and mortality: a seven-year review of a single institution's experience. J Thorac Cardiovasc Surg 2007; 134:194-198.
59. Chen JY, Zhu YH, Jin CH, et al. Successful treatment of multidrug resistant tuberculosis by double lung transplantation. Ann Thorac Surg 2009; 87:1611-1613.